Reimon Yamaguchi

Dr. Reimon Yamaguchi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RYReimon Yamaguchi
Reimon Yamaguchi
XGXin Guo
Xin Guo
JZJianbo Zheng
Jianbo Zheng
JZJing Zhang
Jing Zhang
JHJia Han
Jia Han
SYSohsuke Yamada
Sohsuke Yamada

5 January 2023 in The Journal of Dermatology
Verified
Journal Article
Open access
ASAkira Shimizu
Akira Shimizu
RYReimon Yamaguchi
Reimon Yamaguchi
YKYuko Kuriyama
Yuko Kuriyama
More than 200 types of human papillomavirus (HPV) have been reported to date and have been associated with various dermatological diseases. Among dermatological diseases, viral verrucae are the most commonly reported to be associated with HPV. Epidermodysplasia verruciformis (EV) consists of three types: typical EV is an autosomal recessive genetic disorder with TMC6/TMC8 gene mutations, atypical EV develops due to various gene mutations that cause immunodeficiency, and acquired EV develops due to acquired immunodeficiency. Generalized verrucosis differs from EV in that it involves numerous verrucous nodules (mainly on the limbs), histopathologically no blue cells as seen in EV, and infection with cutaneous α‐HPVs as well as β‐HPVs. HPV‐induced skin malignancies include squamous cell carcinoma (SCC) caused by β‐HPV (especially HPV types 5 and 8) in EV patients, organ transplant recipients, and healthy individuals, and SCC of the vulva and nail unit caused by mucosal high‐risk HPV infection. Carcinogenesis of β‐HPV is associated with sunlight. Mucosal high‐risk HPV‐associated carcinomas may also be sexually transmitted. We focused on Bowen's disease of the nail, which has been the subject of our research for a long time and has recently come to the fore in the field of dermatology.

9 December 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
XMXiangjin Meng
Xiangjin Meng
XGXin Guo
Xin Guo
JZJing Zhang
Jing Zhang
JMJunji Moriya
Junji Moriya
JKJunji Kobayashi
Junji Kobayashi
SYSohsuke Yamada
Sohsuke Yamada
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide, and its treatment remain a constant challenge. A number of clinical trials have shown that acupuncture treatment has beneficial effects for patients with NAFLD, but the molecular mechanisms underlying its action are still largely unknown. In this study, we established a mouse model of NAFLD by administering a methionine- and choline-deficient (MCD) diet and selected three acupoints (ST36, CV4, and KI1) or nonacupoints (sham) for needling. We then investigated the effects of acupuncture treatment on the progression of NAFLD and the underlying mechanisms. After two weeks of acupuncture treatment, the liver in the needling-nonapcupoint group (NG) mice appeared pale and yellowish in color, while that in the needling-acupoint group (AG) showed a bright red color. Histologically, fewer lipid droplets and inflammatory foci were observed in the AG liver than in the NG liver. Furthermore, the expression of proinflammatory signaling factors was significantly downregulated in the AG liver. A lipid analysis showed that the levels of triglyceride (TG) and free fatty acid (FFA) were lower in the AG liver than in the NG liver, with an altered expression of lipid metabolism-related factors as well. Moreover, the numbers of 8-hydroxy-2′-deoxyguanosine (8-OHdG)-positive hepatocytes and levels of hepatic thiobarbituric acid reactive substances (TBARS) were significantly lower in AG mice than in NG mice. In line with these results, a higher expressions of antioxidant factors was found in the AG liver than in the NG liver. Our results indicate that acupuncture repressed the progression of NAFLD by inhibiting inflammatory reactions, reducing oxidative stress, and promoting lipid metabolism of hepatocytes, suggesting that this approach might be an important complementary treatment for NAFLD.

12 May 2023 in The Journal of Dermatology
Verified
Journal Article
Closed access
HOHiroto Ono
Hiroto Ono
RYReimon Yamaguchi
Reimon Yamaguchi
MAMinako Arai
Minako Arai
STSumihito Togi
Sumihito Togi
HUHiroki Ura
Hiroki Ura
ASAkira Shimizu
Akira Shimizu

29 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JHJia Han
Jia Han
XGXin Guo
Xin Guo
TKTomoyuki Koyama
Tomoyuki Koyama
DKDaichi Kawai
Daichi Kawai
JZJing Zhang
Jing Zhang
SYSohsuke Yamada
Sohsuke Yamada
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases with no approved treatment. Zonarol, an extract from brown algae, has been proven to have anti-inflammatory and antioxidant effects. In this study, we investigated the role of zonarol in the progression of methionine- and choline-deficiency (MCD) diet-induced NAFLD in mice. After oral treatment with zonarol, a lighter body weight was observed in zonarol group (ZG) mice in comparison to control group (CG) mice. The NAFLD scores of ZG mice were lower than those of CG mice. Hepatic and serum lipid levels were also lower in ZG mice with the reduced expression of lipid metabolism-related factors. Furthermore, ZG mice showed less lipid deposition, less inflammatory cell infiltration and lower inflammatory cytokine levels in comparison to CG mice. Moreover, the numbers of 8-hydroxy-20-deoxyguanosine (8-OHdG)-positive hepatocytes and levels of hepatic and serum thiobarbituric acid reactive substances (TBARS) were significantly lower in comparison to CG mice. The expression levels of nuclear factor erythroid 2 related factor 2 (Nrf2), as well as its upstream and downstream molecules, changed in ZG mice. Zonarol could prevent the progression of NAFLD by decreasing inflammatory responses, oxidative stress and improving lipid metabolism. Meanwhile the Nrf2 pathway may play an important role in these effects.

24 May 2024 in The Journal of Dermatology
Verified
Journal Article
Closed access
SOSawako Ochiai
Sawako Ochiai
KAKazushi Anzawa
Kazushi Anzawa
RYReimon Yamaguchi
Reimon Yamaguchi
YTYuko Takamiya
Yuko Takamiya
HOHiroto Ono
Hiroto Ono
ASAkira Shimizu
Akira Shimizu